Biomark Diagnostics (XCNQ:BUX) Other Current Liabilities : C$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Other Current Liabilities?

Biomark Diagnostics's other current liabilities for the quarter that ended in Dec. 2024 was C$0.00 Mil.

Biomark Diagnostics's quarterly other current liabilities increased from Jun. 2024 (C$0.00 Mil) to Sep. 2024 (C$0.00 Mil) but then declined from Sep. 2024 (C$0.00 Mil) to Dec. 2024 (C$0.00 Mil).

Biomark Diagnostics's annual other current liabilities increased from Mar. 2022 (C$-0.00 Mil) to Mar. 2023 (C$0.00 Mil) but then stayed the same from Mar. 2023 (C$0.00 Mil) to Mar. 2024 (C$0.00 Mil).

Biomark Diagnostics Other Current Liabilities Historical Data

The historical data trend for Biomark Diagnostics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Other Current Liabilities Chart

Biomark Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Current Liabilities

Get a 7-Day Free Trial

Biomark Diagnostics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Biomark Diagnostics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Biomark Diagnostics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (XCNQ:BUX) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

BMKDF:USA 20B:Germany

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Executives

Rashid Ahmed Maula Bux	Director
Guoyu Huang	Senior Officer

Biomark Diagnostics Headlines

No Headlines